{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320995969536.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/hep.26180"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.26180"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/01515467-201307000-00015"}}],"dc:title":[{"@value":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title>\n          <jats:sec>\n            <jats:title/>\n            <jats:p>Chronic hepatitis B virus (HBV) infection leads to cirrhosis and hepatocellular carcinoma (HCC). Antiviral agents are thought to reduce HCC development, but agents such as lamivudine (LAM) have a high rate of drug resistance. We compared the incidence of HCC in 472 entecavir (ETV)-treated patients and 1,143 nontreated HBV patients (control group). Propensity score matching eliminated the baseline differences, resulting in a sample size of 316 patients per cohort. The drug mutation resistance was 0.8% (4/472) in the ETV group. The cumulative HCC incidence rates at 5 years were 3.7% and 13.7% for the ETV and control groups, respectively (<jats:italic toggle=\"yes\">P</jats:italic> < 0.001). Cox proportional hazard regression analysis, adjusted for a number of known HCC risk factors, showed that patients in the ETV group were less likely to develop HCC than those in the control group (hazard ratio: 0.37; 95% confidence interval: 0.15-0.91; <jats:italic toggle=\"yes\">P</jats:italic> = 0.030). Both cohorts were applied in three previously reported risk scales and risk scores were generated based on age, gender, cirrhosis status, levels of alanine aminotransferase, hepatitis B e antigen, baseline HBV DNA, albumin, and bilirubin. The greatest HCC risk reduction occurred in high-risk patients who scored higher on respective risk scales. In sub analyses, we compared treatment effect between nucleos(t)ide analogs, which included matched LAM-treated patients without rescue therapy (n = 182). We found HCC suppression effect greater in ETV-treated (<jats:italic toggle=\"yes\">P</jats:italic> < 0.001) than nonrescued LAM-treated (<jats:italic toggle=\"yes\">P</jats:italic> = 0.019) cirrhosis patients when they were compared with the control group. <jats:italic toggle=\"yes\">Conclusion</jats:italic>: Long-term ETV treatment may reduce the incidence of HCC in HBV-infected patients. The treatment effect was greater in patients at higher risk of HCC. (HEPATOLOGY 2013)</jats:p>\n          </jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320995969538","@type":"Researcher","foaf:name":[{"@value":"Tetsuya Hosaka"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969536","@type":"Researcher","foaf:name":[{"@value":"Fumitaka Suzuki"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969665","@type":"Researcher","foaf:name":[{"@value":"Masahiro Kobayashi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969541","@type":"Researcher","foaf:name":[{"@value":"Yuya Seko"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969544","@type":"Researcher","foaf:name":[{"@value":"Yusuke Kawamura"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969537","@type":"Researcher","foaf:name":[{"@value":"Hitomi Sezaki"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969545","@type":"Researcher","foaf:name":[{"@value":"Norio Akuta"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969540","@type":"Researcher","foaf:name":[{"@value":"Yoshiyuki Suzuki"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969543","@type":"Researcher","foaf:name":[{"@value":"Satoshi Saitoh"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969664","@type":"Researcher","foaf:name":[{"@value":"Yasuji Arase"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969542","@type":"Researcher","foaf:name":[{"@value":"Kenji Ikeda"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969539","@type":"Researcher","foaf:name":[{"@value":"Mariko Kobayashi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320995969666","@type":"Researcher","foaf:name":[{"@value":"Hiromitsu Kumada"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"02709139"}],"prism:publicationName":[{"@value":"Hepatology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2013-07","prism:volume":"58","prism:number":"1","prism:startingPage":"98","prism:endingPage":"107"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["http://doi.wiley.com/10.1002/tdm_license_1.1"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.26180"},{"@id":"https://journals.lww.com/01515467-201307000-00015"}],"createdAt":"2012-12-05","modifiedAt":"2024-12-01","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002215326694016","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002215482011904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004231260693376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235963698176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142497809664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Non-Genomic Control of Dynamic MYCN Gene Expression in Liver Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142905954944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Deep sequencing analysis of serum hepatitis B virus‐RNA during nucleot(s)ide analogue therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168808127360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Envelope Proteins of Hepatitis B Virus: Molecular Biology and Involvement in Carcinogenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168879457536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The association between hepatocarcinogenesis and intracellular alterations due to hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430195451136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025431128279936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Alteration of Gene Expression After Entecavir and Pegylated Interferon Therapy in HBV-Infected Chimeric Mouse Liver"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283692546753920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283695965035264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710756364160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hepatitis B virus core‐related antigen levels predict progression to liver cirrhosis in hepatitis B carriers"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710756540032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Association between <i>HLA‐DQA1/DRB1</i> polymorphism and development of hepatocellular carcinoma during entecavir treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643784538496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757191892480","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865548261888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181214550656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prediction of development of hepatocellular carcinoma using a new scoring system involving virtual touch quantification in patients with chronic liver diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181466116736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181983660928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185478523264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical implications of serum <scp><i>Wisteria floribunda</i></scp> agglutinin‐positive Mac‐2‐binding protein in treatment‐naïve chronic hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186770124544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Putting “sticky notes” on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580230612674560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Automated fibrosis phenotyping of liver tissue from non-tumor lesions of patients with and without hepatocellular carcinoma after liver transplantation for non-alcoholic fatty liver disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232188278784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Possible biological mechanisms of entecavir <i>versus</i> tenofovir disoproxil fumarate on reducing the risk of hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232408112512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Factors for the recurrence of hepatocellular carcinoma after hepatic resection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584339749273600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Kinetics of HBcrAg and HBsAg using highly sensitive iTACT assays in chronic hepatitis B patients with HBsAg seroclearance"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584341837696000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Usefulness of the Fibrosis‐4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360585257125358080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Soluble Programmed Cell Death-1 Predicts Hepatocellular Carcinoma Development During Nucleoside Analogue Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848662514329728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848664563272064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848664610468096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Association between Serum Cytokine and Chemokine Levels and Antiviral Response by Entecavir Treatment in Chronic Hepatitis B Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567435460992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A global scientific strategy to cure hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567467952768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Signal Activation of Hepatitis B Virus–Related Hepatocarcinogenesis by Up-regulation of SUV39h1"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593780121984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865814743789568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131420431880960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412893228926720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Lipid desaturation-associated endoplasmic reticulum stress regulates MYCN gene expression in hepatocellular carcinoma cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204794926976","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"本邦におけるB型慢性肝疾患からの肝発癌予測リスクスコアモデル（Japanese risk estimations of HBV-related HCC：JAB-HCC）の作成"},{"@language":"en","@value":"A new risk estimation scale of HCC development, named JAB-HCC score (Japanese risk estimations of HBV-related HCC), shows a good discrimination capability"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204794968192","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A case of multiple hepatocellular carcinoma with inferior vena cava thrombosis which was resectable after multimodality therapy"},{"@language":"ja","@value":"集学的治療により根治切除可能となった下大静脈腫瘍栓合併多発肝細胞癌の1例"},{"@value":"症例報告 集学的治療により根治切除可能となった下大静脈腫瘍栓合併多発肝細胞癌の1例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク シュウガクテキ チリョウ ニ ヨリ コンジ セツジョ カノウ ト ナッタ シタ ダイ ジョウミャク シュヨウセン ガッペイ タハツ カン サイボウガン ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206361001344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"1．肝疾患診療の現状と進歩"},{"@language":"en","@value":"1. Clinincal Diagnosis and Medical Care of Liver Disease, Present Situation and Progress"},{"@value":"肝臓疾患(特に肝細胞がん)の診断から治療まで(1)肝疾患診療の現状と進歩"},{"@language":"ja-Kana","@value":"カンゾウ シッカン(トクニ カン サイボウ ガン)ノ シンダン カラ チリョウ マデ(1)カン シッカン シンリョウ ノ ゲンジョウ ト シンポ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390023936882295552","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"B型肝炎について"},{"@language":"ja-Kana","@value":"Bガタ カンエン ニ ツイテ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679772150912","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"当院における肝炎ウイルス検査の実施状況と陽性者に対する受診勧奨システム構築による院内連携の変化について"},{"@language":"en","@value":"Promotion of intra-hospital referral of hepatitis B and C virus carriers to hepatology specialists by electronic medical record-based alert system: a case study at a university hospital"},{"@language":"ja-Kana","@value":"トウ イン ニ オケル カンエンウイルス ケンサ ノ ジッシ ジョウキョウ ト ヨウセイシャ ニ タイスル ジュシン カンショウ システム コウチク ニ ヨル インナイ レンケイ ノ ヘンカ ニ ツイテ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680174044544","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"Transient elastography（FibroScan）による肝硬度測定"},{"@language":"en","@value":"Liver stiffness measurement by transient elastography (FibroScan)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680174699904","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Topics in the hepatitis viruses in the evaluation and promotion of health"},{"@language":"ja","@value":"ウイルス性肝炎の検診にあたって知っておきたいこと"}]},{"@id":"https://cir.nii.ac.jp/crid/1390302646673945600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Higher FIB-4 index at baseline predicts development of liver cancer in a community-based cohort with viral hepatitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390568456357556608","@type":"Article","resourceType":"エディトリアル(editorial)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"What Can Be Done to Address the Exhaustive Referral of Patients with Viral Hepatitis to Specialists?"},{"@value":"Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals"}]},{"@id":"https://cir.nii.ac.jp/crid/1390845713037670144","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"II．核酸アナログ薬時代の B型肝発癌抑止"},{"@language":"en","@value":"II. Reduction of hepatocellular carcinoma incidence in nucleos (t) ide analogues era"},{"@value":"核酸アナログ薬時代のB型肝発癌抑止"},{"@language":"ja-Kana","@value":"カクサン アナログヤク ジダイ ノ Bガタ カンハツガン ヨクシ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390851242929370368","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efforts to identify HCV antibody-positive patients in a medium-sized hospital by \"Team hepatitis\" composed of hospital staff with a hepatitis medical care coordinator"},{"@language":"ja","@value":"肝炎医療コーディネーターを中心とした多職種で構成された「チーム肝炎」による中規模病院でのウイルス肝炎患者の拾い上げの取り組みとその評価"},{"@language":"ja-Kana","@value":"カンエン イリョウ コーディネーター オ チュウシン ト シタ タショクシュ デ コウセイ サレタ 「 チーム カンエン 」 ニ ヨル チュウキボ ビョウイン デ ノ ウイルス カンエン カンジャ ノ ヒロイアゲ ノ トリクミ ト ソノ ヒョウカ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390851940045888384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Promotion of intrahospital referral of hepatitis virus-positive patients to hepatology specialists through interprofessional collaboration, including clinical laboratory technicians"},{"@language":"ja","@value":"臨床検査技師を含む多職種連携による院内肝炎ウイルス検査陽性者受診勧奨の取り組み"},{"@language":"ja-Kana","@value":"リンショウ ケンサ ギシ オ フクム タショクシュ レンケイ ニ ヨル インナイ カンエンウイルス ケンサ ヨウセイシャ ジュシン カンショウ ノ トリクミ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390857357571994112","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The great results of our unique intrahospital cooperation alert system for positive hepatitis C test results"},{"@language":"ja","@value":"C型肝炎ウイルス検査陽性患者に対する院内連携システムの構築と運用による拾い上げ効果"},{"@language":"ja-Kana","@value":"Cガタカンエンウイルス ケンサ ヨウセイ カンジャ ニ タイスル インナイ レンケイ システム ノ コウチク ト ウンヨウ ニ ヨル ヒロイアゲ コウカ"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/hep.26180"},{"@type":"OPENAIRE","@value":"doi_dedup___::93a001ac5f41131cd4af002df963398a"},{"@type":"CROSSREF","@value":"10.1007/s00535-017-1424-0_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1007/s12072-017-9799-9_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1007/s00535-014-1010-7_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1128/aac.00725-17_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.2957/kanzo.57.7_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.2957/kanzo.62.337_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.3389/fonc.2020.618515_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1111/hepr.13574_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.3390/v13061124_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1111/liv.15065_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.2957/kanzo.63.522_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.3390/cells14060428_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.3390/v16111743_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1093/infdis/jiv572_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.4254/wjh.v7.i22.2404_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1111/jgh.13989_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1111/jgh.14454_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.4748-20_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.535_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.7143/jhep.40.281_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.2169/naika.107.19_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0261878_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.3390/ijms23147878_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1111/hepr.14016_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1007/s00535-016-1228-7_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1007/s12072-015-9647-8_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1111/hepr.12703_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1186/s12879-016-1765-y_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1007/s12072-022-10340-9_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1111/jgh.16178_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1007/s00535-023-01962-3_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1002/jmv.29109_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1111/hepr.13957_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0146314_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.3748/wjg.v22.i32.7252_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.2957/kanzo.56.477_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.2957/kanzo.62.448_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1016/s2468-1253(19)30119-0_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1093/infdis/jiaa317_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1038/s41598-021-03706-w_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1038/s41598-021-01014-x_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.3851/imp3196_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.35772/ghm.2024.01008_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1097/hep.0000000000000459_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1272/manms.21.193_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1016/j.canlet.2018.07.019_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1111/hepr.13391_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.1038/s41419-020-2257-y_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.3179/jjmu.jjmu.r.46_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"},{"@type":"CROSSREF","@value":"10.6009/jjrt.2015_jsrt_71.12.1265_references_DOI_YN7F6W5Cu2j8i3lpHpTuJBNhLNy"}]}